Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised …

T Kishimoto, K Hagi, S Kurokawa, JM Kane… - The Lancet …, 2021 - thelancet.com
Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia

G Kaplan, J Casoy, J Zummo - Patient preference and adherence, 2013 - Taylor & Francis
Schizophrenia is a debilitating chronic disease that requires lifelong medical care and
supervision. Even with treatment, the majority of patients relapse within 5 years, and suicide …

Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies

T Kishimoto, K Hagi, M Nitta, S Leucht… - Schizophrenia …, 2018 - academic.oup.com
Compared with oral antipsychotics (OAPs), long-acting injectable antipsychotics (LAIs)
should improve medication adherence and reduce relapses in schizophrenia. However …

[HTML][HTML] Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial …

U Stentzel, N van den Berg, LN Schulze… - BMC psychiatry, 2018 - Springer
Background Schizophrenia and bipolar disorder are characterized by a high disease
burden. Antipsychotic medication is an essential part of the treatment. However, non …

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis

G Medic, K Higashi, KJ Littlewood, T Diez… - Neuropsychiatric …, 2013 - Taylor & Francis
Background The purpose of this study was to investigate the impact of dosing frequency on
adherence in severe chronic psychiatric and neurological diseases. Methods: A systematic …

Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophrenia

J Lin, B Wong, S Offord, D Mirski - … journal of behavioral health services & …, 2013 - Springer
Real-world medication adherence and healthcare costs of patients with schizophrenia
initiating long-acting injectable (LAI) vs. oral antipsychotics were compared. Patients with …

A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral …

A Kopelowicz, RA Baker, C Zhao… - Neuropsychiatric …, 2017 - Taylor & Francis
Background Medication nonadherence is common in the treatment of serious mental illness
(SMI) and leads to poor outcomes. The digital medicine system (DMS) objectively measures …

Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage

S Offord, J Lin, B Wong, D Mirski, RA Baker - Community mental health …, 2013 - Springer
Nonadherence to antipsychotic medications is widespread and compromises the outcome of
patients with schizophrenia. Using the MarketScan Medicare claims database, this study …

[HTML][HTML] Specialized inpatient treatment for young people with early psychosis: acute-treatment and 12-month results

S Siebert, K Leopold, J Baumgardt… - European Archives of …, 2022 - Springer
The objective of the study was to investigate the development of clinical outcomes of young
people with early psychosis in a specialized inpatient treatment and assess the feasibility of …

Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary

I Bitter, L Katona, J Zámbori, P Takács, L Fehér… - European …, 2013 - Elsevier
We conducted a nationwide, full-population based investigation to evaluate the comparative
effectiveness of all marketed second generation antipsychotic drugs (SGA) prescribed for …